NEW YORK (GenomeWeb News) - Arizona's Translational Genomics Research Institute plans to boost its workforce in the coming year, maintaining the double-digit pace of growth it highlighted in a recent economic impact study.

"It will be about 80 percent research investigation, about evenly divided between computational biology and wet labs, with really only about a fifth of the positions coming in the area of administrative project management," Jeffrey Trent, TGen's president and research director, told GenomeWeb Daily News earlier this week.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.